Literature DB >> 30243508

Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy.

Weimin Wang1, Weiping Zou2, J Rebecca Liu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30243508      PMCID： PMC6263945          DOI： 10.1016/j.ygyno.2018.09.005

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  22 in total

1.  Significance of serum and peritoneal fluid lactate dehydrogenase levels in ovarian cancer.

Authors:  N Boran; F Kayikçioğlu; S Yalvaç; G Tulunay; U Ekinci; M F Köse
Journal:  Gynecol Obstet Invest       Date:  2000       Impact factor: 2.031

Review 2.  Adoptive immunotherapy for cancer: harnessing the T cell response.

Authors:  Nicholas P Restifo; Mark E Dudley; Steven A Rosenberg
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

Review 3.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

Review 4.  Immunosuppressive networks in the tumour environment and their therapeutic relevance.

Authors:  Weiping Zou
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  An immunogenic personal neoantigen vaccine for patients with melanoma.

Authors:  Patrick A Ott; Zhuting Hu; Derin B Keskin; Sachet A Shukla; Jing Sun; David J Bozym; Wandi Zhang; Adrienne Luoma; Anita Giobbie-Hurder; Lauren Peter; Christina Chen; Oriol Olive; Todd A Carter; Shuqiang Li; David J Lieb; Thomas Eisenhaure; Evisa Gjini; Jonathan Stevens; William J Lane; Indu Javeri; Kaliappanadar Nellaiappan; Andres M Salazar; Heather Daley; Michael Seaman; Elizabeth I Buchbinder; Charles H Yoon; Maegan Harden; Niall Lennon; Stacey Gabriel; Scott J Rodig; Dan H Barouch; Jon C Aster; Gad Getz; Kai Wucherpfennig; Donna Neuberg; Jerome Ritz; Eric S Lander; Edward F Fritsch; Nir Hacohen; Catherine J Wu
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

6.  Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.

Authors:  Ugur Sahin; Evelyna Derhovanessian; Matthias Miller; Björn-Philipp Kloke; Petra Simon; Martin Löwer; Valesca Bukur; Arbel D Tadmor; Ulrich Luxemburger; Barbara Schrörs; Tana Omokoko; Mathias Vormehr; Christian Albrecht; Anna Paruzynski; Andreas N Kuhn; Janina Buck; Sandra Heesch; Katharina H Schreeb; Felicitas Müller; Inga Ortseifer; Isabel Vogler; Eva Godehardt; Sebastian Attig; Richard Rae; Andrea Breitkreuz; Claudia Tolliver; Martin Suchan; Goran Martic; Alexander Hohberger; Patrick Sorn; Jan Diekmann; Janko Ciesla; Olga Waksmann; Alexandra-Kemmer Brück; Meike Witt; Martina Zillgen; Andree Rothermel; Barbara Kasemann; David Langer; Stefanie Bolte; Mustafa Diken; Sebastian Kreiter; Romina Nemecek; Christoffer Gebhardt; Stephan Grabbe; Christoph Höller; Jochen Utikal; Christoph Huber; Carmen Loquai; Özlem Türeci
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

7.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

8.  Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma.

Authors:  Hongwei Zhang; Jiaqi Lu; Yingying Lu; Jiayi Zhou; Zehua Wang; Haiou Liu; Congjian Xu
Journal:  PLoS One       Date:  2017-05-12       Impact factor: 3.240

9.  Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy.

Authors:  Shu-Lin Yu; Li-Tao Xu; Qi Qi; Ya-Wen Geng; Hao Chen; Zhi-Qiang Meng; Peng Wang; Zhen Chen
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

Review 10.  Immune checkpoint blockade in ovarian cancer.

Authors:  Lukas Weiss; Florian Huemer; Brigitte Mlineritsch; Richard Greil
Journal:  Memo       Date:  2016-06-02
View more
  7 in total

1.  Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high-grade serous ovarian cancer.

Authors:  Guodong Zhang; Qing Xu; Xiangyun Zhang; Moran Yang; Yiying Wang; Mengdi He; Jiaqi Lu; Haiou Liu
Journal:  Cancer Med       Date:  2021-05-05       Impact factor: 4.452

Review 2.  Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.

Authors:  Sima Chaudhari; Satyajit Dey Pereira; Meshach Asare-Warehene; Ritam Naha; Shama Prasada Kabekkodu; Benjamin K Tsang; Kapaettu Satyamoorthy
Journal:  J Ovarian Res       Date:  2021-02-25       Impact factor: 4.234

3.  Spatially resolved transcriptomics of high-grade serous ovarian carcinoma.

Authors:  Elaine Stur; Sara Corvigno; Mingchu Xu; Ken Chen; Yukun Tan; Sanghoon Lee; Jinsong Liu; Emily Ricco; Daniel Kraushaar; Patricia Castro; Jianhua Zhang; Anil K Sood
Journal:  iScience       Date:  2022-02-14

4.  Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes.

Authors:  Xiaoyan Shen; Xiao Gu; Ruiqiong Ma; Xiaoping Li; Jianliu Wang
Journal:  Front Cell Dev Biol       Date:  2022-03-17

Review 5.  The Role of T Cells in Ovarian Physiology and Infertility.

Authors:  Laura O Knapik; Shubangi Paresh; Dalileh Nabi; Lynae M Brayboy
Journal:  Front Cell Dev Biol       Date:  2022-04-26

6.  Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.

Authors:  Zi-Qian Liang; Rong-Quan He; Jia-Yuan Luo; Zhi-Guang Huang; Jie Li; Lu-Yang Zhong; Jun-Hong Chen; Su-Ning Huang; Lin Shi; Kang-Lai Wei; Jiang-Hui Zeng; Jing-Jing Zeng; Gang Chen
Journal:  Pathol Oncol Res       Date:  2022-07-15       Impact factor: 2.874

7.  Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer.

Authors:  Alyssa A Hoover; Demetra H Hufnagel; Whitney Harris; Kennady Bullock; Evan B Glass; Esther Liu; Whitney Barham; Marta A Crispens; Dineo Khabele; Todd D Giorgio; Andrew J Wilson; Fiona E Yull
Journal:  BMC Cancer       Date:  2020-10-07       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.